AU6153200A - Use of creatine and/or creatine derivatives for treating feelings of ill-health in women - Google Patents

Use of creatine and/or creatine derivatives for treating feelings of ill-health in women

Info

Publication number
AU6153200A
AU6153200A AU61532/00A AU6153200A AU6153200A AU 6153200 A AU6153200 A AU 6153200A AU 61532/00 A AU61532/00 A AU 61532/00A AU 6153200 A AU6153200 A AU 6153200A AU 6153200 A AU6153200 A AU 6153200A
Authority
AU
Australia
Prior art keywords
creatine
feelings
women
ill
health
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61532/00A
Other languages
English (en)
Inventor
Helen Louise Holland
Andrea Huber
Ralf Jager
Ivo Pischel
Brigitta Schwartz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
SKW Trostberg AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19929995A external-priority patent/DE19929995B4/de
Application filed by SKW Trostberg AG filed Critical SKW Trostberg AG
Publication of AU6153200A publication Critical patent/AU6153200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU61532/00A 1999-06-30 2000-06-29 Use of creatine and/or creatine derivatives for treating feelings of ill-health in women Abandoned AU6153200A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19929995A DE19929995B4 (de) 1999-06-30 1999-06-30 Verwendung von Kreatin und/oder Kreatin-Derivaten zur Behandlung von Befindlichkeitsstörungen bei Frauen
DE19929995 1999-06-30
US09/491,662 US6503951B2 (en) 1999-06-30 2000-01-27 Use of creatine and/or creatine derivatives for treating typical disorders in women
US09491662 2000-01-27
PCT/EP2000/006084 WO2001003325A2 (de) 1999-06-30 2000-06-29 Verwendung von kreatin und/oder kreatin-derivaten zur behandlung von befindlichkeitsstörungen bei frauen

Publications (1)

Publication Number Publication Date
AU6153200A true AU6153200A (en) 2001-01-22

Family

ID=26053993

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61532/00A Abandoned AU6153200A (en) 1999-06-30 2000-06-29 Use of creatine and/or creatine derivatives for treating feelings of ill-health in women

Country Status (2)

Country Link
AU (1) AU6153200A (de)
WO (1) WO2001003325A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10003835A1 (de) * 2000-01-28 2001-08-16 Sueddeutsche Kalkstickstoff Formulierungen bei Dehydratationszuständen
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
EP1688139A1 (de) * 2000-09-14 2006-08-09 Board of Regents of the University of Nebraska Kreatinester-Verbindungen und -Formulierungen
US9833427B2 (en) 2000-09-14 2017-12-05 Board Of Regents Of The University Of Nebraska Creatine ester anti-inflammatory compounds and formulations
US20030212136A1 (en) 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
EP1414469A2 (de) * 2001-08-09 2004-05-06 Degussa Food Ingredient GmbH Formulierung enthaltend (lyso-) phosphatidylserin zur vorbeugung und behandlung von stresszuständen bei warmblütern

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017794A1 (en) * 1993-02-03 1994-08-18 Steven Andrew Jennings Blends of glycine derivatives and sugars
US5627172A (en) * 1994-03-04 1997-05-06 Natural Supplement Association, Incorporated Method for reduction of serum blood lipids or lipoprotein fraction
CA2235350C (en) * 1994-11-08 2009-01-06 Avicena Group, Inc. Use of creatine or creatine analogs for the treatment of diseases of the nervous system
SK283195B6 (sk) * 1996-12-20 2003-03-04 Degussa Ag Kreatínpyruváty, spôsob ich výroby a farmaceutický prostriedok
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
JP2000515559A (ja) * 1997-06-25 2000-11-21 アイ・ピー・アール・インシティチュート・フォー・ファーマシューティカル・リサーチ・エー・ジー 体重減量方法

Also Published As

Publication number Publication date
WO2001003325A2 (de) 2001-01-11
WO2001003325A3 (de) 2001-08-02

Similar Documents

Publication Publication Date Title
AU6872498A (en) Method and composition for skin treatment
AU6012900A (en) Apparatus and method for treating body tissues with electricity or medicaments
HK1048949A1 (en) Method and composition for the treatment of scars
AU4564200A (en) Method for treating cancer using camptothecin derivatives and 5-fluorouracil
AU5788300A (en) Medical treatment method and kit
EE9900519A (et) Stent ja meetod stendi paigaldamiseks kehasisesesse luumenisse
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
PL352330A1 (en) Derivatives of pyridopyranoazepine, making of same and use of same in therapy
WO2001028494A3 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
ZA989885B (en) Use of macrolides for the treatment of cancer and macular degeneration
AU5774699A (en) Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders
AU2001292019A1 (en) Protein prenyl transferase inhibitors in the treatment of neuroinflammatory disease
AU2741300A (en) Apparatus and method of photo-specific tissue treatment
PL352333A1 (en) Dihydrobenzodiazepines and use of same in treatment of dislipidemia
AU2001241877A1 (en) Methods for detection and treatment of neural cancers
AU6153200A (en) Use of creatine and/or creatine derivatives for treating feelings of ill-health in women
AU4608296A (en) Methods and compositions for treatment of solid tumors in vivo
HUP0202444A3 (en) Method and kit for immuno-detecting bacteria in blood and tissues
AU4744500A (en) Method and apparatus for selection and evaluation of substances in treatment of bone disorders
AU2001276462A1 (en) Use of natural products in cancer treatment
AU1710001A (en) Method and arrangement for determining suitable treatment frequency and/or intensity
AU2420101A (en) Method and composition for the treatment of pain
PL342055A1 (en) Application of hydropyridones containing powders in treating crural ulcerations and bedsores
HUP0101299A3 (en) Use of topiramate and derivatives for manufacturing medicament useful for treating schizophrenia
AU3996799A (en) Alpha amino acid composition and method for the treatment of skin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase